132 related articles for article (PubMed ID: 29966762)
41. Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules.
Nonhoff U; Ralser M; Welzel F; Piccini I; Balzereit D; Yaspo ML; Lehrach H; Krobitsch S
Mol Biol Cell; 2007 Apr; 18(4):1385-96. PubMed ID: 17392519
[TBL] [Abstract][Full Text] [Related]
42. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau.
Taniguchi-Watanabe S; Arai T; Kametani F; Nonaka T; Masuda-Suzukake M; Tarutani A; Murayama S; Saito Y; Arima K; Yoshida M; Akiyama H; Robinson A; Mann DMA; Iwatsubo T; Hasegawa M
Acta Neuropathol; 2016 Feb; 131(2):267-280. PubMed ID: 26538150
[TBL] [Abstract][Full Text] [Related]
43. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
44. Further understanding of tau phosphorylation: implications for therapy.
Medina M; Avila J
Expert Rev Neurother; 2015 Jan; 15(1):115-22. PubMed ID: 25555397
[TBL] [Abstract][Full Text] [Related]
45. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
46. Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies.
Stanford PM; Brooks WS; Teber ET; Hallupp M; McLean C; Halliday GM; Martins RN; Kwok JB; Schofield PR
J Neurol; 2004 Sep; 251(9):1098-104. PubMed ID: 15372253
[TBL] [Abstract][Full Text] [Related]
47. The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies.
Nijholt DA; van Haastert ES; Rozemuller AJ; Scheper W; Hoozemans JJ
J Pathol; 2012 Apr; 226(5):693-702. PubMed ID: 22102449
[TBL] [Abstract][Full Text] [Related]
48. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
Sydow A; Mandelkow EM
Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454
[TBL] [Abstract][Full Text] [Related]
49. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
[TBL] [Abstract][Full Text] [Related]
50. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
51. DDX6 Represses Aberrant Activation of Interferon-Stimulated Genes.
Lumb JH; Li Q; Popov LM; Ding S; Keith MT; Merrill BD; Greenberg HB; Li JB; Carette JE
Cell Rep; 2017 Jul; 20(4):819-831. PubMed ID: 28746868
[TBL] [Abstract][Full Text] [Related]
52. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
53. Decoupling the impact of microRNAs on translational repression versus RNA degradation in embryonic stem cells.
Freimer JW; Hu TJ; Blelloch R
Elife; 2018 Jul; 7():. PubMed ID: 30044225
[TBL] [Abstract][Full Text] [Related]
54. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies.
Wagner J; Krauss S; Shi S; Ryazanov S; Steffen J; Miklitz C; Leonov A; Kleinknecht A; Göricke B; Weishaupt JH; Weckbecker D; Reiner AM; Zinth W; Levin J; Ehninger D; Remy S; Kretzschmar HA; Griesinger C; Giese A; Fuhrmann M
Acta Neuropathol; 2015 Nov; 130(5):619-31. PubMed ID: 26439832
[TBL] [Abstract][Full Text] [Related]
55. Systemic and network functions of the microtubule-associated protein tau: Implications for tau-based therapies.
Bakota L; Ussif A; Jeserich G; Brandt R
Mol Cell Neurosci; 2017 Oct; 84():132-141. PubMed ID: 28318914
[TBL] [Abstract][Full Text] [Related]
56. Identification and chromosome mapping of the mouse homologue of the human gene (DDX6) that encodes a putative RNA helicase of the DEAD box protein family.
Akao Y; Matsuda Y
Cytogenet Cell Genet; 1996; 75(1):38-44. PubMed ID: 8995487
[TBL] [Abstract][Full Text] [Related]
57. DDX6 Orchestrates Mammalian Progenitor Function through the mRNA Degradation and Translation Pathways.
Wang Y; Arribas-Layton M; Chen Y; Lykke-Andersen J; Sen GL
Mol Cell; 2015 Oct; 60(1):118-30. PubMed ID: 26412305
[TBL] [Abstract][Full Text] [Related]
58. The DEAD-box RNA-binding protein DDX6 regulates parental RNA decay for cellular reprogramming to pluripotency.
Kami D; Kitani T; Nakamura A; Wakui N; Mizutani R; Ohue M; Kametani F; Akimitsu N; Gojo S
PLoS One; 2018; 13(10):e0203708. PubMed ID: 30273347
[TBL] [Abstract][Full Text] [Related]
59. IP6K1 upregulates the formation of processing bodies by influencing protein-protein interactions on the mRNA cap.
Shah A; Bhandari R
J Cell Sci; 2021 Dec; 134(24):. PubMed ID: 34841428
[TBL] [Abstract][Full Text] [Related]
60. The RNA helicase DDX6 controls early mouse embryogenesis by repressing aberrant inhibition of BMP signaling through miRNA-mediated gene silencing.
Kim J; Muraoka M; Okada H; Toyoda A; Ajima R; Saga Y
PLoS Genet; 2022 Oct; 18(10):e1009967. PubMed ID: 36197846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
